Shenzhen Salubris Pharmaceuticals Co., Ltd. Share Price
Equities
002294
CNE100000FW8
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.81 CNY | +5.59% |
|
+3.46% | +2.54% |
| 02-13 | Salubris Pharmaceuticals Applies for Hong Kong Listing | MT |
| 02-13 | Shenzhen Salubris submits listing application to Hong Kong stock exchange | RE |
| Capitalization | 56.64B 8.21B 7.08B 6.39B 6.13B 11.19B 755B 11.71B 75.57B 30.28B 362B 30.83B 30.17B 1,295B | P/E ratio 2025 * |
84.4x | P/E ratio 2026 * | 71.8x |
|---|---|---|---|---|---|
| Enterprise value | 56.64B 8.21B 7.08B 6.39B 6.13B 11.19B 755B 11.71B 75.57B 30.28B 362B 30.83B 30.17B 1,295B | EV / Sales 2025 * |
12.7x | EV / Sales 2026 * | 10.5x |
| Free-Float |
37.38% | Yield 2025 * |
1.06% | Yield 2026 * | 1.16% |
| 1 day | +5.59% | ||
| 1 week | +3.46% | ||
| Current month | +3.46% | ||
| 1 month | +7.38% | ||
| 3 months | -16.02% | ||
| 6 months | -12.91% | ||
| Current year | +2.54% |
| 1 week | 46.39 |  | 51.72 |
| 1 month | 46.39 | | 54.08 |
| Current year | 44.95 | | 56.17 |
| 1 year | 29.56 | | 65.63 |
| 3 years | 23.5 | | 65.63 |
| 5 years | 20 | | 65.63 |
| 10 years | 16.7 | | 65.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 53 | 22/09/2022 |
Yun Kong
DFI | Director of Finance/CFO | 52 | 29/12/2021 |
Jian Feng Yang
ADM | Chief Administrative Officer | 50 | 31/12/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Hai Ye
CHM | Chairman | 82 | 02/11/1998 |
Sing Ye
CHM | Chairman | 50 | 22/09/2022 |
Jian Feng Yang
BRD | Director/Board Member | 50 | 19/08/2010 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.59% | +3.46% | +69.20% | +43.82% | 7.78B | |
| +0.83% | +3.59% | +11.49% | +86.42% | 46.62B | |
| -1.08% | -6.07% | +34.56% | +154.04% | 34.02B | |
| -4.02% | -7.39% | +291.59% | +1,228.70% | 12.46B | |
| -0.39% | -2.00% | -9.62% | +49.98% | 11.67B | |
| -0.17% | -0.94% | +0.62% | +91.76% | 10.02B | |
| -0.86% | -4.17% | +37.31% | +115.96% | 8.17B | |
| +1.12% | -5.74% | +54.85% | -10.22% | 7.43B | |
| +0.73% | -0.58% | +52.10% | +404.43% | 6.48B | |
| -1.54% | -3.77% | +5.90% | +50.69% | 6.33B | |
| Average | +0.02% | -1.83% | +54.80% | +221.56% | 15.1B | |
| Weighted average by Cap. | -0.10% | -1.63% | +45.47% | +200.26% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.48B 649M 560M 505M 485M 884M 59.66B 925M 5.97B 2.39B 28.61B 2.44B 2.38B 102B | 5.39B 782M 674M 609M 584M 1.06B 71.87B 1.11B 7.2B 2.88B 34.46B 2.93B 2.87B 123B |
| Net income | 667M 96.69M 83.36M 75.25M 72.21M 132M 8.89B 138M 890M 356M 4.26B 363M 355M 15.24B | 776M 113M 97.03M 87.59M 84.04M 153M 10.34B 160M 1.04B 415M 4.96B 422M 413M 17.74B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 50.81 ¥ | +5.59% | 10,608,010 |
| 05/03/26 | 48.12 ¥ | +2.95% | 5,900,996 |
| 04/03/26 | 46.74 ¥ | -2.48% | 6,114,248 |
| 03/03/26 | 47.93 ¥ | -1.78% | 6,550,485 |
| 02/03/26 | 48.80 ¥ | -0.63% | 6,889,282 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002294 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition